Zhejiang Starry Pharmaceutical Co., Ltd.SSE: 603520

Announcement on Implementation of Dividend Distribution for 2025

May 29, 2026 · Issued by Zhejiang Starry Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · May 29, 2026

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-404

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Starry Pharmaceutical

Announcement on Election of Employee Representative Directors for the 6th Board of DirectorsMay 23
Announcement on Resolutions of the 2025 Annual General MeetingMay 21
Announcement on Obtaining Government SubsidiesMay 12
Announcement on the Actual Controller Adding a Concerted Party and a Plan for Internal Transfer of Shares among Persons Acting in Concert and Shareholding Reduction PlanMay 8
Indicative Announcement on Election of Board of Directors at Expiry of Term of OfficeApr 30

Later from Zhejiang Starry Pharmaceutical

Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026Jun 9
Announcement on Resolutions of the 1st Meeting of the 6th Board of DirectorsJun 16
Announcement on Release of the Pledge over Shares Held by the Controlling ShareholderJul 4
Announcement on Pledge of Partial Shares of Controlling ShareholderJul 8
Change in Equity of Shareholders with Over 5% Shares Reaching 1% ThresholdJul 14

All Zhejiang Starry Pharmaceutical news releases

Follow Zhejiang Starry Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang Starry Pharmaceutical